Literature DB >> 8615131

Electron microscopy of Lewy bodies in the amygdala-parahippocampal region. Comparison with inclusion bodies in the MPTP-treated squirrel monkey.

L S Forno1, L E DeLanney, I Irwin, J W Langston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8615131

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  10 in total

1.  Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome.

Authors:  Doris Petroi; Blagovesta Popova; Naimeh Taheri-Talesh; Stefan Irniger; Hedieh Shahpasandzadeh; Markus Zweckstetter; Tiago F Outeiro; Gerhard H Braus
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

Review 2.  Mitochondrial mechanisms of redox cycling agents implicated in Parkinson's disease.

Authors:  Pamela Lopert; Manisha Patel
Journal:  J Neural Transm (Vienna)       Date:  2015-03-07       Impact factor: 3.575

3.  Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.

Authors:  Michael G Schlossmacher; Matthew P Frosch; Wei Ping Gai; Miguel Medina; Nutan Sharma; Lysia Forno; Tomoyo Ochiishi; Hideki Shimura; Ronit Sharon; Nobutaka Hattori; J William Langston; Yoshikuni Mizuno; Bradley T Hyman; Dennis J Selkoe; Kenneth S Kosik
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

4.  Interplay between sumoylation and phosphorylation for protection against α-synuclein inclusions.

Authors:  Hedieh Shahpasandzadeh; Blagovesta Popova; Alexandra Kleinknecht; Paul E Fraser; Tiago F Outeiro; Gerhard H Braus
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

5.  Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse model.

Authors:  Xu Zhang; Jian-Ying Zhou; Mark H Chin; Athena A Schepmoes; Vladislav A Petyuk; Karl K Weitz; Brianne O Petritis; Matthew E Monroe; David G Camp; Stephen A Wood; William P Melega; Diana J Bigelow; Desmond J Smith; Wei-Jun Qian; Richard D Smith
Journal:  J Proteome Res       Date:  2010-03-05       Impact factor: 4.466

6.  Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease.

Authors:  Zhanyun Lv; Hong Jiang; Huamin Xu; Ning Song; Junxia Xie
Journal:  J Neural Transm (Vienna)       Date:  2010-06-17       Impact factor: 3.575

Review 7.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

8.  Parkin-mediated ubiquitination regulates phospholipase C-gamma1.

Authors:  Nodi Dehvari; Anna Sandebring; Amilcar Flores-Morales; Laura Mateos; Yin-Choy Chuan; Matthew S Goldberg; Mark R Cookson; Richard F Cowburn; Angel Cedazo-Mínguez
Journal:  J Cell Mol Med       Date:  2008-07-30       Impact factor: 5.310

9.  Postmortem studies in Parkinson's disease.

Authors:  Andreas Hartmann
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

10.  The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.

Authors:  Anne-Laure Mahul-Mellier; Johannes Burtscher; Niran Maharjan; Laura Weerens; Marie Croisier; Fabien Kuttler; Marion Leleu; Graham W Knott; Hilal A Lashuel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-19       Impact factor: 11.205
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.